Mike W. Helms

826 total citations
21 papers, 591 citations indexed

About

Mike W. Helms is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Mike W. Helms has authored 21 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in Mike W. Helms's work include RNA Interference and Gene Delivery (4 papers), Advanced biosensing and bioanalysis techniques (4 papers) and RNA Research and Splicing (2 papers). Mike W. Helms is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Advanced biosensing and bioanalysis techniques (4 papers) and RNA Research and Splicing (2 papers). Mike W. Helms collaborates with scholars based in Germany, United States and Belgium. Mike W. Helms's co-authors include Burkhard Brandt, Christopher H. Contag, Horst Buerger, Werner Boecker, Jens Packeisen, Christos Tsatsanis, Christina Doxaki, Birgit Schittek, Christian August and Dirk Kemming and has published in prestigious journals such as The Journal of Immunology, Journal of Molecular Biology and Cancer Research.

In The Last Decade

Mike W. Helms

20 papers receiving 585 citations

Peers

Countries citing papers authored by Mike W. Helms

Since Specialization

Citations

This map shows the geographic impact of Mike W. Helms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike W. Helms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike W. Helms more than expected).

Fields of papers citing papers by Mike W. Helms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike W. Helms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike W. Helms. The network helps show where Mike W. Helms may publish in the future.

Co-authorship network of co-authors of Mike W. Helms

This figure shows the co-authorship network connecting the top 25 collaborators of Mike W. Helms. A scholar is included among the top collaborators of Mike W. Helms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike W. Helms. Mike W. Helms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trivalent siRNA-Conjugates with Guanosine as ASGPR-Binder Show Potent Knock-Down In Vivo 2025 ·Journal of Medicinal Chemistry ·(unknown), Kerstin Jahn‐Hofmann, Bodo Brunner, Mike W. Helms, (unknown), (unknown), Gernot Zech, Ziyu Li, Gerhard Heßler, Herman Schreuder, Bettina Elshorst, (unknown), Michael Kurz, (unknown), Sabine Scheidler	0
2	Small Interfering RNAs Containing Dioxane- and Morpholino-Derived Nucleotide Analogues Show Improved Off-Target Profiles and Chirality-Dependent In Vivo Knock-Down 2022 ·Journal of Medicinal Chemistry ·(unknown), Kerstin Jahn‐Hofmann, Bodo Brunner, Mike W. Helms, (unknown), (unknown), Michael Kurz, (unknown), Sabine Scheidler	4
3	Syntheses of Morpholine-Based Nucleotide Analogs for Hepatic siRNA Targeting and Stabilization 2021 ·Journal of Medicinal Chemistry ·(unknown), Kerstin Jahn‐Hofmann, Bodo Brunner, Mike W. Helms, (unknown), (unknown), Michael Kurz, Ziyu Li, (unknown), (unknown), Oliver Plettenburg, Sabine Scheidler	4
4	Nanobody–siRNA Conjugates for Targeted Delivery of siRNA to Cancer Cells 2021 ·Molecular Pharmaceutics ·(unknown), Bodo Brunner, Peter Casteels, (unknown), (unknown), Carlo Boutton, Mike W. Helms, Timothy R. Wagenaar, (unknown), (unknown), (unknown), Pieter Deschaght, Sabine Scheidler, Kerstin Jahn‐Hofmann	23
5	Engagement of community stakeholders to develop a framework to guide research dissemination to communities 2020 ·Health Expectations ·Jennifer Cunningham‐Erves, Tilicia Mayo‐Gamble, Yolanda Vaughn, (unknown), Mike W. Helms, (unknown), Yvonne Joosten	21
6	Utility of the RIG-I Agonist Triphosphate RNA for Melanoma Therapy 2019 ·Molecular Cancer Therapeutics ·Mike W. Helms, Kerstin Jahn‐Hofmann, Felix Gnerlich, (unknown), Monika Braun, (unknown), (unknown), Kaj Grandien, Joachim Theilhaber, Hui Cao, Timothy R. Wagenaar, Max Schnurr, Stefan Endres, Dmitri Wiederschain, Sabine Scheidler, Simon Rothenfußer, Bodo Brunner, Lars M. König	13
7	Akt2 Deficiency Protects from Acute Lung Injury via Alternative Macrophage Activation and miR-146a Induction in Mice 2013 ·The Journal of Immunology ·Eleni Vergadi, Katerina Vaporidi, (unknown), Christina Doxaki, Eleni Lagoudaki, Eleftheria Ieronymaki, Vasileia Ismini Alexaki, Mike W. Helms, Εumorfia Kondili, (unknown), Efstathios N. Stathopoulos, Andrew N. Margioris, Dimitrios Georgopoulos, Christos Tsatsanis	135
8	Image-guided genomic analysis of tissue response to laser-induced thermal stress 2011 ·Journal of Biomedical Optics ·Mark A. Mackanos, Mike W. Helms, Flora Kalish, Christopher H. Contag	5
9	IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy 2010 ·Cancer Immunology Immunotherapy ·Mike W. Helms, Jennifer A. Prescher, Yuan Cao, Steven Schaffert, Christopher H. Contag	46
10	TOB1 Is Regulated by EGF-Dependent HER2 and EGFR Signaling, Is Highly Phosphorylated, and Indicates Poor Prognosis in Node-Negative Breast Cancer 2009 ·Cancer Research ·Mike W. Helms, Dirk Kemming, Christopher H. Contag, Heike Pospisil, Kai Bartkowiak, Alice Wang, Sheng-Yung Chang, Horst Buerger, Burkhard Brandt	33
11	Quantifying Cell-Surface Biomarker Expression in Thick Tissues with Ratiometric Three-Dimensional Microscopy 2009 ·Biophysical Journal ·Jonathan Liu, Mike W. Helms, Michael J. Mandella, James M. Crawford, G. S. Kino, Christopher H. Contag	55
12	Ratiometric 3D scanning cytometer for quantifying cell-surface biomarker expression within intact tissues 2009 ·Jonathan Liu, Michael J. Mandella, Mike W. Helms, James M. Crawford, Christopher H. Contag, G. S. Kino	2
13	Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease 2008 ·British Journal of Cancer ·Mike W. Helms, Dirk Kemming, Heike Pospisil, U Vogt, Horst Buerger, Eberhard Korsching, C Liedtke, C. M. Schlotter, (unknown), Stephen Chan, Burkhard Brandt	47
14	Options for Visualizing Metastatic Disease in the Living Body 2006 ·PubMed ·Mike W. Helms, Burkhard Brandt, Christopher H. Contag	2
15	Whole Genome Expression Analysis for Biologic Rational Pathway Modeling 2006 ·Molecular Diagnosis & Therapy ·Dirk Kemming, U Vogt, Nicola Tidow, C. M. Schlotter, Horst Bürger, Mike W. Helms, Eberhard Korsching, A Granetzny, (unknown), Ludger Hillejan, Alessandro Marra, (unknown), (unknown), Burkhard Brandt	8
16	[Expression of early placenta insulin-like growth factor (EPIL) in breast cancer cells provides an autocrine loop with enhancement of predominantly HER-2-related invasivity]. 2005 ·PubMed ·Horst Bürger, Dirk Kemming, Mike W. Helms, U. Feldmann, (unknown), W. Böcker, (unknown)	2
17	Expression of early placenta insulin-like growth factor in breast cancer cells provides an autocrine loop that predominantly enhances invasiveness and motility 2005 ·Endocrine Related Cancer ·Burkhard Brandt, Dirk Kemming, Jens Packeisen, Ronald Simon, Mike W. Helms, U. Feldmann, (unknown), Christian Kersting, Bernd Hinrichs, (unknown), (unknown), Kai Bartkowiak, (unknown), Thomas Dittmar, Guido Sauter, Werner Boecker, Horst Buerger	20
18	First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor‐positive breast cancer 2005 ·The Journal of Pathology ·Mike W. Helms, Jens Packeisen, Christian August, Birgit Schittek, Werner Boecker, Burkhard Brandt, Horst Buerger	75
19	Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry 2004 ·British Journal of Cancer ·Eberhard Korsching, Jens Packeisen, Mike W. Helms, Christian Kersting, (unknown), P. J. van Diest, Burkhard Brandt, Elsken van der Wall, Werner Boecker, Horst Bürger	26
20	Activation Mechanism of Pro-astacin: Role of the Pro-peptide, Tryptic and Autoproteolytic Cleavage and Importance of Precise Amino-terminal Processing 2002 ·Journal of Molecular Biology ·Irene Yiallouros, Reinhild Kappelhoff, Oliver Schilling, Frank Wegmann, Mike W. Helms, (unknown), (unknown), (unknown), (unknown), Hans‐Jürgen Hinz, Simone König, Jasna Peter‐Katalinić, Walter Stöcker	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact